SomaLogic, Inc. (SLGC): Price and Financial Metrics


SomaLogic, Inc. (SLGC): $5.75

-0.02 (-0.35%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SLGC Stock Price Chart Interactive Chart >

Price chart for SLGC

SLGC Price/Volume Stats

Current price $5.75 52-week high $14.72
Prev. close $5.77 52-week low $4.20
Day low $5.52 Volume 1,670,800
Day high $5.80 Avg. volume 1,207,379
50-day MA $6.83 Dividend yield N/A
200-day MA $9.83 Market Cap 1.05B

SomaLogic, Inc. (SLGC) Company Bio


SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow-offrate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company's SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development. Its SomaScan's biomarker discoveries help in diagnostic applications in various areas of diseases, including cardiovascular and metabolic disease, nonalcoholic steatohepatitis, wellness, and others. The company's solutions also include SomaSignal tests, which are research use only tests for clinical trial applications. It serves research and clinical customers with a focus on pharmaceutical and biotechnology companies, and academic research institutions; and facilitates drug development, analysis of clinical trials, and new human biology insights by assessing protein-protein and protein-gene networks. The company was incorporated in 1999 and is headquartered in Boulder, Colorado.


SLGC Latest News Stream


Event/Time News Detail
Loading, please wait...

SLGC Latest Social Stream


Loading social stream, please wait...

View Full SLGC Social Stream

Latest SLGC News From Around the Web

Below are the latest news stories about SomaLogic Inc that investors may wish to consider to help them evaluate SLGC as an investment opportunity.

SomaLogic (SLGC) Investor Presentation - Slideshow

No summary available.

Seeking Alpha | February 21, 2022

Did Hedge Funds Catch A Break With SomaLogic Inc. (SLGC) ?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

Insider Monkey | February 5, 2022

SomaLogic provides revenue guidance above consensus mark

SomaLogic (SLGC) stated Friday that it expects its FY22 revenue to range between $105-$110M vs

Seeking Alpha | February 4, 2022

SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting

BOULDER, Colo., Feb. 04, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, will host a virtual analyst and investor meeting today, February 4th, 2022, from 10:00 a.m. to approximately 1:00 p.m. Eastern Time. The event is intended to highlight recent corporate updates, technical specifications and capabilities of the SomaScan platform, and various applications across life science tools and clinical diagnostics. SomaLogic management will be joined by leadi

Yahoo | February 4, 2022

SomaLogic to Participate in Upcoming Investor Conferences

BOULDER, Colo., Feb. 02, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following virtual investor conferences. BTIG MedTech, Digital Health, Life Science & Diagnostic Tools ConferencePresentation on Tuesday, February 15 at 10:30 a.m. ET11th Annual SVB Leerink Global Healthcare ConferencePresentation on Thursday, February 17 at 10:40 a.m. ET Interested parties may access a live and archived

Yahoo | February 2, 2022

Read More 'SLGC' Stories Here

SLGC Price Returns

1-mo -14.18%
3-mo -33.60%
6-mo -53.48%
1-year -50.58%
3-year N/A
5-year N/A
YTD -50.60%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.8079 seconds.